Health Condition 1: F988- Other specified behavioral and emotional disorders with onset usually occurring in childhood and adolescence
Conditions
Interventions
Intervention1: Vitamin D3: Dose: 60000 IU
Frequency: 2 weeks once
Duration: 2 months
Control Intervention1: Occupational therapy + Speech therapy: Dose: NA
Frequency: 3 times a week
Route of administration: NA
Duration: 2 months
Sponsors
SRM Institute of Science and Technology
Eligibility
Inclusion criteria
Inclusion criteria: 1. Mild-to-moderate ASD children diagnosed using Childhood Autism Rating Scale, Second Edition-Standard Version (CARS2-ST) 2. Parents who are willing to give written informed consent
Exclusion criteria
Exclusion criteria: 1. Children undergoing any chronic drug treatment 2. Severe intellectual disability 3. History of seizure 4. Presence of hepatic disease 5. Having any other genetic and chromosomal syndromes • Children with chronic illness or known hormonal and metabolic diseases • Parents will be informed not to change the number of hours and frequency of sessions of occupational and speech therapy during the study period. Parents will also be informed not to change routine food habits during the study period. If the research team identify any violation of these, they will also be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| change in vitamin D3 levels between baseline and at the end of 3 months.Timepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| change in the scores of CARS2-ST, Autism Treatment Evaluation Checklist (ATEC), BEARS sleep screening tool and 6-item Gastrointestinal Severity Index (6-GSI) between baseline and at the end of 3 months.Timepoint: 3 months | — |
Countries
India
Contacts
Public ContactDR MG Rajanandh
SRM Institute of Science and Technology
Outcome results
None listed